Overview

A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status

Status:
RECRUITING

Trial end date:
2027-10-31

Target enrollment:

Participant gender:

Summary

This is an interventional study to explore the efficacy and safety of denosumab combined chemotherapy and anti-PD-1/PD-L1 inhibitor in locally advanced or metastatic NSCLC.

Phase:

PHASE2

Details

Lead Sponsor:

China Medical University, China

Treatments:

Drug Therapy